While it has been previously published that anti-CTLA-4 or PD-1 monotherapy induces infiltration by TILs [105–108], this study suggests that CD8+ T cells infiltrating the tumor before therapy are particularly correlated with tumor response during therapy. This evidence concerns the gene CD8A and neoplasm.